Daryn Grossman

Daryn A. Grossman is a Partner in the New York office, head of the Life Sciences Group and co-head of the Technology, Media & Communications Group. Referred to by Chambers USA as “skilled and resourceful” and commended by IAM Licensing 250 2010 for her life sciences expertise, Daryn concentrates in technology and intellectual property-related transactions and advises clients in identifying, protecting, and exploiting intellectual property assets. She joined Proskauer after heading up the New York Technology Practice of Brobeck, Phleger & Harrison LLP.

Daryn focuses her practice on the biotechnology, pharmaceutical and medical device fields. She has extensive experience in structuring and negotiating complex transactions where intellectual property assets drive the deals, such as outsourcing transactions, corporate partnering transactions, domestic and international joint ventures, strategic equity investments, spin-offs, development, licensing and distribution agreements, and sponsored research and clinical trial arrangements. Daryn also counsels venture capitalists and strategic investors in evaluating intellectual property portfolios in connection with private equity investments, public offerings and mergers and acquisitions. She has a global practice and advises clients with respect to business partners based in the U.S., Europe, South America, Asia, Australia, Israel and Canada.

Her clients include companies in the biotechnology, pharmaceutical and medical device fields. She represents entities in all stages: from start-up ventures just beginning to assemble IP portfolios to Fortune 500 companies with well-established IP programs. Daryn has been involved in successful deals with parties such as Amgen, Novartis, Merck, Pfizer, Bayer AG, Hoffman LaRoche, Mundipharma, Eli Lilly & Co., Medtronic, Bard, Johnson & Johnson, Janssen, Biocryst Pharmaceuticals, Boston Scientific Corporation, 3D Pharmaceuticals, Celgene Corporation, Les Laboratories Servier, sanofi-aventis, Aspen Pharmacare, sanofi-pasteur, Shimoda Biotech (Pty) Ltd., Recoly N.V., Roche Pharmaceuticals, Exosome Diagnostics, University of Melbourne, Albert Einstein College of Medicine, Columbia University, Mt. Sinai School of Medicine, Emory University, Le Centre National de la Recherche Scientifique, University of Bath, University of St. Andrew's, St. Jude Children's Research Hospital and Duke University.

Daryn is a frequent lecturer on entrepreneurship and issues related to life sciences, technology, licensing and intellectual property law.